# Platinum Equity to acquire LifeScan from Johnson & Johnson for $2.1B

Johnson & Johnson announced a binding offer from Platinum Equity to acquire its LifeScan business for approximately $2.1 billion. LifeScan is a leader in blood glucose monitoring products. The transaction is expected to close by the end of 2018.

- Type: Acquisition
- Announced: 2018-03-16
- Where: United States
- Value: $2.10B
- Status: announced
- Products: blood glucose monitoring products, OneTouch brand products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Platinum Equity](https://endata.com/companies/1087.md) (acquirer)
- [Johnson & Johnson](https://endata.com/companies/9845.md) (partner)
- [LifeScan](https://endata.com/companies/30790.md) (target)

## Sources

- [investor.jnj.com](https://www.investor.jnj.com/investor-news/news-details/2018/Johnson-Johnson-Announces-Binding-Offer-from-Platinum-Equity-to-Acquire-LifeScan-Inc.-03-16-2018/default.aspx), 2018-03-16: "This initiative is part of our ongoing, disciplined approach to portfolio management to focus on our most promising opportunities to help patients and drive growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.